Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Once-daily Oral Avatrombopag in Japanese Subjects With Chronic Liver Diseases and Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating once-daily avatrombopag for thrombocytopenia associated with chronic liver disease in Japanese subjects; completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia Associated with Chronic Liver Disease

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Thrombocytopenia Associated With Chronic Liver Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-02-28